130 related articles for article (PubMed ID: 9805184)
1. Beneficial effect of phlebotomy on hepatitis C virus-associated musculoskeletal manifestations.
Hilzenrat N; Buskila D; Zilberman D; Sikuler E
Clin Rheumatol; 1998; 17(5):390-2. PubMed ID: 9805184
[TBL] [Abstract][Full Text] [Related]
2. A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.
Fong TL; Han SH; Tsai NC; Morgan TR; Mizokami M; Qian D; Phan C; Goad K; Redeker AG
J Hepatol; 1998 Mar; 28(3):369-74. PubMed ID: 9551672
[TBL] [Abstract][Full Text] [Related]
3. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
[TBL] [Abstract][Full Text] [Related]
4. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G
Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729
[TBL] [Abstract][Full Text] [Related]
5. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
Di Bisceglie AM; Bonkovsky HL; Chopra S; Flamm S; Reddy RK; Grace N; Killenberg P; Hunt C; Tamburro C; Tavill AS; Ferguson R; Krawitt E; Banner B; Bacon BR
Hepatology; 2000 Jul; 32(1):135-8. PubMed ID: 10869301
[TBL] [Abstract][Full Text] [Related]
6. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
Girelli CM; Mirata C; Casiraghi A
Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
[TBL] [Abstract][Full Text] [Related]
7. Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection.
Kawamura Y; Akuta N; Sezaki H; Hosaka T; Someya T; Kobayashi M; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2005 Sep; 40(9):901-6. PubMed ID: 16211347
[TBL] [Abstract][Full Text] [Related]
8. Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy.
Herrera JL
Am J Gastroenterol; 1999 Dec; 94(12):3571-5. PubMed ID: 10606321
[TBL] [Abstract][Full Text] [Related]
9. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I
Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478
[TBL] [Abstract][Full Text] [Related]
10. Effects of dietary iron reduction versus phlebotomy in patients with chronic hepatitis C: results from a randomized, controlled trial on 40 Japanese patients.
Sumida Y; Kanemasa K; Fukumoto K; Yoshida N; Sakai K
Intern Med; 2007; 46(10):637-42. PubMed ID: 17527035
[TBL] [Abstract][Full Text] [Related]
11. Extrahepatic manifestations in chronic hepatitis C virus carriers.
Rosenthal E; Cacoub P
Lupus; 2015 Apr; 24(4-5):469-82. PubMed ID: 25801890
[TBL] [Abstract][Full Text] [Related]
12. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy.
Tsai NC; Zuckerman E; Han SH; Goad K; Redeker AG; Fong TL
Am J Gastroenterol; 1997 Oct; 92(10):1831-4. PubMed ID: 9382046
[TBL] [Abstract][Full Text] [Related]
13. Comparative study between occult hepatitis C virus infection and chronic hepatitis C.
Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Castillo I; Carreño V
J Viral Hepat; 2007 Jan; 14(1):36-40. PubMed ID: 17212642
[TBL] [Abstract][Full Text] [Related]
14. Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial.
Gentile I; Viola C; Paesano L; D'Onofrio M; D'Agostino E; Cerini R; Borrelli F; Piazza M; Borgia G
J Clin Apher; 2009; 24(5):190-6. PubMed ID: 19760753
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
[TBL] [Abstract][Full Text] [Related]
16. Iron and proinflammatory cytokines in chronic hepatitis C virus infection.
López-Prieto J; González-Reimers E; Alemán-Valls MR; de la Vega-Prieto MJ; Abreu-González P; Pelazas-González R; Hernández-Luis R; Jorge-Ripper C; Santolaria-Fernández F
Biol Trace Elem Res; 2013 Oct; 155(1):5-10. PubMed ID: 23892696
[TBL] [Abstract][Full Text] [Related]
17. [Significance of iron reduction for the therapy of chronic hepatitis C].
Nozić D; Balint B; Stanković N; Dimitrijević J; Nesković G
Vojnosanit Pregl; 2005 Feb; 62(2):161-4. PubMed ID: 15787170
[TBL] [Abstract][Full Text] [Related]
18. [Chronic hepatitis C virus infection: An internist's opinion (Part 1)].
Zubkin ML; Chervinko VI; Ovchinnikov YV; Kryukov EV; Kotenko ON
Ter Arkh; 2016; 88(10):105-113. PubMed ID: 28635859
[TBL] [Abstract][Full Text] [Related]
19. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
Fontana RJ; Israel J; LeClair P; Banner BF; Tortorelli K; Grace N; Levine RA; Fiarman G; Thiim M; Tavill AS; Bonkovsky HL
Hepatology; 2000 Mar; 31(3):730-6. PubMed ID: 10706565
[TBL] [Abstract][Full Text] [Related]
20. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection.
Barrett S; Goh J; Coughlan B; Ryan E; Stewart S; Cockram A; O'Keane JC; Crowe J
Gut; 2001 Sep; 49(3):423-30. PubMed ID: 11511566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
